Influence of Serum Markers on Small Cell Lung Cancer Prognosis
Author Information
Author(s): Boher J-M, Pujol J-L, Grenier J, Daurès J-P
Primary Institution: Institut Universitaire de Recherche Clinique
Hypothesis
The study investigates the relationship between serum marker levels and prognosis in small cell lung cancer during chemotherapy.
Conclusion
High serum NSE levels and advanced tumor stage are associated with a worse prognosis in small cell lung cancer, but patients can revert to a lower risk state.
Supporting Evidence
- High serum NSE levels are a negative prognostic factor for small cell lung cancer.
- Patients with high marker levels have a significantly increased risk of death.
- There is a possibility for patients to revert from high to low marker levels.
Takeaway
Doctors looked at blood tests to see how they affect the chances of getting better from lung cancer, and found that some tests can show if a patient is doing worse, but sometimes patients can improve.
Methodology
A Markov model was used to analyze the prognostic significance of changes in serum marker levels and tumor status during chemotherapy.
Statistical Information
P-Value
< 0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website